1. Home
  2. XNCR vs VTLE Comparison

XNCR vs VTLE Comparison

Compare XNCR & VTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • VTLE
  • Stock Information
  • Founded
  • XNCR 1997
  • VTLE 2006
  • Country
  • XNCR United States
  • VTLE United States
  • Employees
  • XNCR N/A
  • VTLE N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • VTLE
  • Sector
  • XNCR Health Care
  • VTLE
  • Exchange
  • XNCR Nasdaq
  • VTLE Nasdaq
  • Market Cap
  • XNCR 547.8M
  • VTLE 593.6M
  • IPO Year
  • XNCR 2013
  • VTLE 2011
  • Fundamental
  • Price
  • XNCR $13.61
  • VTLE $16.10
  • Analyst Decision
  • XNCR Buy
  • VTLE Hold
  • Analyst Count
  • XNCR 11
  • VTLE 11
  • Target Price
  • XNCR $22.20
  • VTLE $25.22
  • AVG Volume (30 Days)
  • XNCR 1.3M
  • VTLE 970.2K
  • Earning Date
  • XNCR 11-05-2025
  • VTLE 11-05-2025
  • Dividend Yield
  • XNCR N/A
  • VTLE N/A
  • EPS Growth
  • XNCR N/A
  • VTLE N/A
  • EPS
  • XNCR N/A
  • VTLE N/A
  • Revenue
  • XNCR $146,929,000.00
  • VTLE $1,935,411,000.00
  • Revenue This Year
  • XNCR $23.31
  • VTLE $0.55
  • Revenue Next Year
  • XNCR N/A
  • VTLE N/A
  • P/E Ratio
  • XNCR N/A
  • VTLE N/A
  • Revenue Growth
  • XNCR N/A
  • VTLE 5.26
  • 52 Week Low
  • XNCR $6.92
  • VTLE $12.30
  • 52 Week High
  • XNCR $27.24
  • VTLE $36.72
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 88.43
  • VTLE 46.00
  • Support Level
  • XNCR $11.36
  • VTLE $15.33
  • Resistance Level
  • XNCR $13.07
  • VTLE $17.70
  • Average True Range (ATR)
  • XNCR 0.63
  • VTLE 0.89
  • MACD
  • XNCR 0.16
  • VTLE -0.14
  • Stochastic Oscillator
  • XNCR 94.92
  • VTLE 20.76

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About VTLE Vital Energy Inc. par value $0.01 per share

Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.

Share on Social Networks: